Jumonji Domain Containing 6, Arginine Demethylase And Lysine Hydroxylase
| Inventor | Institute |
|---|---|
| Yvan Canitrot | Toulouse Tech Transfer |
| SKU: | 161708 |
|---|---|
| Product description: | Jumonji Domain Containing 6, Arginine Demethylase And Lysine Hydroxylase |
| Alternate name: | JMJD6 KO U2OS cell line |
| Gender: | Female |
| CRISPR: | Yes |
| Conditional: | No |
| Production details: | Gene inactivation by CRISPR-Cas9 and reintroduction of JMJD6 via stable expression of a plasmid coding for JMJD6 |
| Receptors of note: | Insulin like growth factor |
| Parental cell line: | U2OS |
| Model description: | JMJD6 knock out using CRISPR-Cas9 |
| Disease: | Myasthenic Syndrome |
| Related tools: | V5-tagged form of JMJD6 U2OS cell line, Catalytically-inactive-JMJD6 U2OS cell line |
| Cat. #: | 161708 |
|---|---|
| Tool sub type: | Continuous |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Bone |
| Gender: | Female |
| Model: | Knock-Out |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Primary citation: | Fages et al. 2020. PLoS Genet 16(6):e e1008511. PMID: 32598339. |
| Storage conditions: | Liquid Nitrogen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | DMEM medium supplemented with 10% foetal calf serum, sodium pyruvate and antibiotics (penicillin/streptomycin) |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Recommended controls: | Parental U2OS cell line, JMJD6 WT cell lines |
| Biosafety level: | 1 |
| References: |
Fages et al. 2020. PLoS Genet 16(6):e e1008511. PMID: 32598339. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.